Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2017-10-25Clinical Trial Update: Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Update notes that Olaparib is available via an expanded access program as maintenance therapy for ovarian, fallopian tube, or primary perito…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors [Phase 2]
Phase 2 trial of combination chemotherapy with pegfilgrastim in previously untreated germ cell tumors has completed, with results posted.
-
CLINICAL_TRIALS withdrawal · 2017-10-10Clinical Trial Update: Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients [Phase 2]
A Phase 2 trial evaluating a carboplatin, eribulin, and veliparib combination in stage IV breast and ovarian cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating recombinant measles virus vaccine therapy and oncolytic virus therapy for progressive, recurrent, or refra…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating apatinib plus etoposide versus etoposide alone for platinum-resistant recurrent ovarian cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) [Phase 2]
Phase 2 study evaluating adavosertib in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in platinum-sensitive …
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of rilotumumab in persistent/recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]
Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids [Phase 1]
Phase 1 trial evaluating a combination of carboplatin, paclitaxel (Taxol), and ridaforolimus in endometrial and ovarian cancers; study statu…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. [NA]
This clinical trial update reports the completion of a study evaluating probe-based and needle-based confocal laser endomicroscopy during gy…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating apatinib as a third-line therapy for advanced ovarian cancer, focusing on efficacy and safety. The update …
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [Phase 2]
This Phase 2 trial evaluated the combination of sargramostim with paclitaxel albumin-stabilized nanoparticle formulation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) [Phase 2]
A Phase 2 study comparing DNIB0600A to pegylated liposomal doxorubicin in platinum-resistant ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Phase I Platinum Based Chemotherapy Plus Indomethacin [Phase 1]
Phase I study of platinum-based chemotherapy in combination with indomethacin for colorectal, esophageal, and ovarian cancers has completed.…
-
CLINICAL_TRIALS withdrawal · 2017-08-18Clinical Trial Update: Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression. [Phase 2]
A Phase 2 trial in recurrent ovarian cancer evaluating two doses of a study drug with low-dose cyclophosphamide after response to platinum-b…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer [Phase 1]
This Phase 1 trial update reports results for a NY-ESO-1 vaccine with the GLA-SE adjuvant in patients with unresectable or metastatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: TIL Therapy for Metastatic Ovarian Cancer [Phase 1]
Phase 1 clinical trial update of tumor-infiltrating lymphocyte (TIL) therapy for metastatic ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer [Phase 2]
Phase 2 clinical trial comparing intraperitoneal versus intravenous chemotherapy after neoadjuvant treatment in ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification [NA]
A completed clinical trial evaluating whether altering dietary macronutrient intake can disrupt cancer metabolism and growth in ovarian and …
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer
This clinical trial update reports the results of a completed study evaluating bevacizumab in combination with front-line chemotherapy for o…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has bee…
-
FDA approval · 2017-08-03FDA Approved: GEMCITABINE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's gemcitabine injectable drug as an original application, providing a generic version of the anticancer agent…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia [Phase 2]
Completed Phase 2 trial evaluating intraperitoneal intraoperative paclitaxel chemotherapy for peritoneal carcinomatosis from ovarian cancer,…
-
CLINICAL_TRIALS research · 2017-08-01Clinical Trial Update: Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer [NA]
Clinical trial update describing the evaluation of surgical excision of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: EURAD-MR Classification : European Multicenter Study
Clinical trial update for EURAD-MR, a European multicenter study investigating ovarian tumors. The trial status is currently unknown.